The structure of a designed peptidomimetic inhibitor complex of alpha-thrombin.
The structure of a designed peptidomimetic inhibitor complex of alpha-thrombin.
复制标题
设计的α-凝血酶拟肽抑制剂复合物的结构。
DOI:
10.1093/protein/6.5.471
复制
发表时间:
1993
期刊:
影响因子:
--
通讯作者:
Kahn,M
中科院分区:
文献类型:
--
作者:
Wu,TP;Yee,V;Tulinsky,A;Chrusciel,RA;Nakanishi,H;Shen,R;Priebe,C;Kahn,M
Thrombin displays remarkable specificity, effecting the removal of fibrinopeptides A and B of fibrinogen through the selective cleavage of two Arg–Gly bonds between the 181 Arg/Lys–Xaa bonds in fibrinogen. Significant advances have been made in recent years towards understanding the origin of the specificity of cleavage of the Argl6–Gly17 bond of the Aα-chain of human fibrinogen. We have previously proposed a model for the bound structure of fibrinopeptide A7–16(FPA), based upon NMR data, computer-assisted molecular modeling and the synthesis and study of peptidomimetic substrates and inhibitors of thrombin. We now report the structure of the ternary complex of an FPA mimetic (FPAM), hirugen and thrombin at 2.5 Å resolution (R-factor = 0.138) and specificity data for the inhibition of thrombin and related trypsin-like proteinases by FPAM. The crystallographic structures of FPA and its chloromethyl ketone derivative bound to thrombin were determined. Although there are differences between these structures in the above modeled FPA structure and that of the crystal structure of FPAM bound to thrombin, the φ, ψ angles in the critical region of P1–P2–P3 in all of the structures are similar to those of bovine pancreatic trypsin inhibitor (BPTI) in the BPTI–trypsin complex and D–Phe–Pro–Arg (PPACK) in the PPACK–thrombin structure. A comparison between these and an NMR-derived structure is carried out and discussed.